Records containing: Urinary Bladder Diseases
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-02A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator, Through 24-Months (INTIBIA Pivotal Study IU024)
-
CLINICAL_TRIALS study record update · 2025-12-26Multicenter Pilot and Exploration Study of Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Urologic Reconstructive Surgery
-
CLINICAL_TRIALS study record update · 2025-12-11modifiCatiOn of fOod intaKe to Influence the Equilibrium of the uRinary BLADDER
-
CLINICAL_TRIALS study record update · 2025-09-03A Phase 2 Trial in Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
-
CLINICAL_TRIALS study record update · 2025-08-14Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-13A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
-
CLINICAL_TRIALS study record update · 2024-10-31Non-Interventional Study Assessing Quality of Life, Treatment Satisfaction, Resource Utilisation, and Persistence With Treatment in Overactive Bladder (OAB) Patients Prescribed Betmiga® - A Multicenter Non-interventional Post Authorisation Study (PAS)
-
CLINICAL_TRIALS study record update · 2024-10-16A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2024-09-19Infectious Complications After Cystectomy: A Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2021-11-08Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans
-
CLINICAL_TRIALS study record update · 2021-10-18A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy, Safety, and Tolerability of JNJ-42160443 in Subjects With Interstitial Cystitis/ Painful Bladder Syndrome
-
CLINICAL_TRIALS study record update · 2021-06-11Safety and Efficacy Study of Tislelizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Patients, a Prospective Open Single-site Trial（TACBIN-01）
-
CLINICAL_TRIALS study record update · 2021-06-04Eosinophilic Cystitis Mimicking Urothelial Neoplasia: A Retrospective Study
-
CLINICAL_TRIALS study record update · 2020-03-10Investigation of Falls and Balance of Patients With Parkinson's Disease With Urinary Disturbance
-
CLINICAL_TRIALS study record update · 2017-10-09A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
-
CLINICAL_TRIALS study record update · 2017-06-16Evaluation of the Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel Mixed With Mitomycin C (MMC) in Non-muscle Invasive Bladder Cancer (NMIBC) Patients
-
CLINICAL_TRIALS study record update · 2016-09-08Evaluation of the Clinical Response of Mitomycin-C (MMC) Embedded in Hydrogel (TC-3) in Comparison to Mitomycin C in Saline, When Administered Intravesically, Pre-TURBT in Non Muscle Invasive Bladder Cancer (NMIBC) Patients. Muscle Invasive Bladder Cancer (NMIBC) Patients
-
CLINICAL_TRIALS study record update · 2016-08-30A Double-Blind, Randomized, Parallel Group, Multi-Centre Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Subjects With Overactive Bladder (OAB) Treated With Antimuscarinics and Dissatisfied Due to Lack of Efficacy
-
CLINICAL_TRIALS study record update · 2016-05-27ClinicalTrials.gov study NCT01930799
-
CLINICAL_TRIALS study record update · 2015-07-21A Randomized, Double-Blind, Factorial, Parallel-Group, Active and Placebo-Controlled, Multicenter Dose-Ranging Study to Evaluate the Efficacy, Safety and Tolerability of Six Dose Combinations of Solifenacin Succinate and Mirabegron Compared to Mirabegron and Solifenacin Succinate Monotherapies in the Treatment of Overactive Bladder.
-
CLINICAL_TRIALS study record update · 2015-04-01A Multi-Centre, Randomised, Open-Label Active-Controlled Study Comparing Safety and Efficacy of Synergo Radiofrequency (RF)-Induced Hyperthermia-Chemotherapy With Mitomycin C (RITE) Versus Bacillus Calmette-Guérin (BCG) as First-Line Treatment of Non-Muscle Invasive Papillary Bladder Cancer (NMIBC)
-
CLINICAL_TRIALS study record update · 2014-10-07A Randomized Controlled Study Comparing Adjuvant Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG Immunotherapy (BCG) Adjuvant Treatment in Patients With Superficial Transitional Cell Carcinoma of the Bladder (STCCB)